Researchers use biomarker to identify cancer-related cognitive impairment
A team of researchers led by Assoc Prof Alexandre Chan from the Dept of Pharmacy at NUS Faculty of Science examined 81 breast cancer patients and found that those who had higher plasma levels of the biomarker dehydroepiandrosterone (DHEA) and its sulfated form (DHEAS) had lower odds of developing cancer-related cognitive impairment.
- 8world, 1 May 2019
- Channel U News, 1 May 2019
mso-ansi-language:EN-SG;mso-fareast-language:ZH-CN;mso-bidi-language:AR-SA">Capital 95.8FM, 3 May 2019